History of aromatase: saga of an important biological mediator and therapeutic target
about
Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cellsHormone action in the mammary glandModulation of Aromatase by PhytoestrogensRoles for miRNAs in endocrine resistance in breast cancerAdipocytes: impact on tumor growth and potential sites for therapeutic interventionUse of aromatase inhibitors in practice of gynecologySmall Molecule Agonists of the Orphan Nuclear Receptors Steroidogenic Factor-1 (SF-1, NR5A1) and Liver Receptor Homologue-1 (LRH-1, NR5A2)Structural Basis for the Functional Roles of Critical Residues in Human Cytochrome P450 AromataseTFF3 is a valuable predictive biomarker of endocrine response in metastatic breast cancer.Clinical utilities of aromatase inhibitors in breast cancerMechanistic Evaluation of Benzo[a]pyrene's Developmental Toxicities Mediated by Reduced Cyp19a1b ActivityLIM-homeodomain transcription factor, Lhx2, is involved in transcriptional control of brain-specific promoter/exon 1f of the mouse aromatase geneCYP19A1 promoter methylation in saliva associated with milestones of pubertal timing in urban girlsEstrogens in Male PhysiologyAromatase deficiency in a Chinese adult man caused by novel compound heterozygous CYP19A1 mutations: effects of estrogen replacement therapy on the bone, lipid, liver and glucose metabolism.Estrogen stimulation of cell migration involves multiple signaling pathway interactionsAnalysis of estrogens in serum and plasma from postmenopausal women: past present, and futureSynaptocrine signaling: steroid synthesis and action at the synapse.Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.Sensitivity to the aromatase inhibitor letrozole is prolonged after a "break" in treatment.Variability in short-wavelength automated perimetry among peri- or postmenopausal women: a dependence on phyto-oestrogen consumption?Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promisesSex steroid metabolism in benign and malignant intact prostate biopsies: individual profiling of prostate intracrinologyDiverse and active roles for adipocytes during mammary gland growth and function.Aromatase inhibitors in pediatrics.Natural compounds with aromatase inhibitory activity: an update.Obesity and cancer--mechanisms underlying tumour progression and recurrenceGenomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs.Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers.The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer.Tissue physiology and pathology of aromatase.Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland.Evidence for an elevated aspartate pK(a) in the active site of human aromataseThe impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer.Aromatase inhibitors and antiepileptic drugs: a computational systems biology analysis.Aromatase activity and bone loss in men.Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancerEvolutionary origins of the estrogen signaling system: insights from amphioxusPharmacological blockade of the aromatase enzyme, but not the androgen receptor, reverses androstenedione-induced cognitive impairments in young surgically menopausal rats
P2860
Q21090900-BD88AF39-6BCD-46FA-A4E1-02001E118BC7Q24604954-5EA943F9-E87F-44A4-AE98-901A0CE48508Q26769876-3BAA7978-3651-4C82-AD39-4C17732567E6Q26783076-FC55FFC9-0897-41C2-859F-59270294EF2FQ26830077-E1A4B162-6CA0-4443-B9E7-C57EFAC79CEEQ27001218-8145A882-6C58-4337-91D5-9CEF4F240CBAQ27667247-17BACA15-9B96-48A8-A22A-3F09D63C1616Q27679279-C71819D6-1D5F-405E-B28F-1C6F3AE1A7DAQ27853155-B8C85345-0838-46FC-87A2-44169B5BD438Q28081168-46FA3C7B-D067-4EE7-B376-37B4182E512EQ28397779-D950A4A4-73AC-483F-8367-6175FA51B907Q28504939-3EFAB313-6898-456A-8979-5AA84E3E81C6Q29109882-A956B154-8BDB-497F-B141-ABC631ECFE3CQ30090708-049AA481-B9E5-46D8-A67A-52DD96593906Q30367669-DA78934F-691A-42AA-9751-4BF7E7765818Q30429931-710C4140-383E-4C36-9241-4A241553D758Q30432877-002C5716-4037-4A31-8C3C-0687DD43D063Q30465105-CCDC41FB-FD8E-4EA2-AF3D-0C30A42F08C8Q33591401-58AB4819-49F7-4372-8903-EFC779C32652Q33700933-A5482A61-1D24-4067-A100-8156DBCF8A97Q33926453-FF641044-11C6-4230-8BE7-99796FCF3FC6Q34002823-AAECA490-6D58-4C02-B657-E0A90526E08EQ34092890-57D787F7-D991-4E31-A78A-C6E8AD8AA699Q34135029-623E9902-2AA5-4DC1-B6CC-D602CA20EDD8Q34227175-38620508-745F-47E9-B08E-28600E2878C5Q34249437-61FE0B02-B948-4538-8642-72FBA387C5AFQ34425077-A9B01683-6E31-49E0-A4BA-849F9D685DF1Q34484372-EF4E6298-3713-44A8-B000-637C235D3359Q34512957-7B5C0D0C-7CA6-4F35-883A-8801B1A3B6F3Q34522279-21A9FBF0-AFB4-49A9-ABD9-17D598966136Q34633879-504F6637-4A9B-4A46-A94A-D9AF4FEC99A6Q34764480-7CBFB167-BF09-4B62-8191-C135F1764559Q34958506-34625713-9865-4315-97D5-A4CC2E5D9D18Q35012609-2BF189BB-B01B-4E84-9AE6-2545A32917CDQ35086171-EE85B384-9399-4CAD-8132-BC140FC085F7Q35101538-D6EC1629-B4EF-4100-8A58-6E52806E9FBFQ35157919-2B517AD0-FE15-4223-A5FC-89BEA634E50BQ35202833-6C5C31A7-589E-4152-A4D1-DB2A6A1B0EE1Q35230768-40862912-A003-4A98-8840-20ED435F8796Q35433662-4CFC1351-4677-4930-A553-3C7C367FB219
P2860
History of aromatase: saga of an important biological mediator and therapeutic target
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
History of aromatase: saga of an important biological mediator and therapeutic target
@ast
History of aromatase: saga of an important biological mediator and therapeutic target
@en
History of aromatase: saga of an important biological mediator and therapeutic target
@nl
type
label
History of aromatase: saga of an important biological mediator and therapeutic target
@ast
History of aromatase: saga of an important biological mediator and therapeutic target
@en
History of aromatase: saga of an important biological mediator and therapeutic target
@nl
prefLabel
History of aromatase: saga of an important biological mediator and therapeutic target
@ast
History of aromatase: saga of an important biological mediator and therapeutic target
@en
History of aromatase: saga of an important biological mediator and therapeutic target
@nl
P2093
P3181
P356
P1433
P1476
History of aromatase: saga of an important biological mediator and therapeutic target
@en
P2093
P304
P3181
P356
10.1210/ER.2008-0016
P407
P577
2009-06-01T00:00:00Z